Financial statements M&M Pharma

Balance sheet of M&M Pharma

Company age:
Age:
11 y. 9 m. 25 d.
Share capital:
Share capital:
30 000 PLN
Profit and loss statement Balance Profitability

Balance sheet data of M&M PHARMA

Year
2018
2019
2020
2021
2023
Total assets 342 087,63 334 861,53 353 827,22 412 238,85 341 683,74
A. Fixed assets 0,00 2 500,00 2 500,00 2 500,00 2 500,00
B. Current assets 342 087,63 332 361,53 351 327,22 409 738,85 339 183,74
C. Share capital contributions (basic funds) 0,00 0,00 0,00 0,00 0,00
D. Own shares (stocks) 0,00 0,00 0,00 0,00 0,00
Total liabilities 342 087,63 334 861,53 353 827,22 412 238,85 341 683,74
A. Equity 226 213,67 181 840,04 213 041,32 359 441,81 308 890,14
B. Liabilities and provisions for liabilities 115 873,96 153 021,49 140 785,90 52 797,04 32 793,60
I. Long-term liabilities 0,00 100 000,00 100 000,00 0,00 0,00
II. Short-term liabilities 115 873,96 53 021,49 40 785,90 52 797,04 32 793,60
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.